middle.news
PainChek Nears FDA Nod, Eyes $100M US Market for Dementia Pain App
9:10am on Monday 21st of July, 2025 AEST
•
Healthcare
Read Story
PainChek Nears FDA Nod, Eyes $100M US Market for Dementia Pain App
9:10am on Monday 21st of July, 2025 AEST
Key Points
Final FDA De Novo submission completed for PainChek Adult App
Regulatory decision expected by late September to early October 2025
Targeting US long-term care market for dementia pain assessment
Existing US partner agreements support swift commercial rollout
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE